Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001655759-25-000048
Filing Date
2025-02-25
Accepted
2025-02-25 06:31:41
Documents
3
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740483094.html 4  
1 FORM 4 wk-form4_1740483094.xml 4 5317
2 EX-24.1 limited_poaxforxsectionx.htm EX-24.1 4904
3 limited_poaxforxsectionx001.jpg GRAPHIC 255411
  Complete submission text file 0001655759-25-000048.txt   363789
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Issuer) CIK: 0001655759 (see all company filings)

EIN.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARVINAS, INC., 5 SCIENCE PARK 395 WINCHESTER AVE. NEW HAVEN CT 06511
Business Address
Houston John G (Reporting) CIK: 0001753537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38672 | Film No.: 25659223